Devonian Health Group, Inc. (TSE:GSD) has released an update.
Devonian Health Group Inc. has announced the appointment of its founder, Dr. André P. Boulet, as the new Chairman of the Board and Chief Operating Officer while retaining his role as Chief Scientific Officer. With a strong background in drug development and a wealth of industry experience, Dr. Boulet’s leadership is aimed to streamline the company’s research and scale-up initiatives. The outgoing Chairman, Mr. David Baker, will continue his involvement as a board member.
For further insights into TSE:GSD stock, check out TipRanks’ Stock Analysis page.
